Methyprylon
From Wikipedia, the free encyclopedia
| Image:Methyprylon.png | |
|
Methyprylon
|
|
| Systematic (IUPAC) name | |
| 3,3-diethyl-5-methyl-piperidine-2,4-dione | |
| Identifiers | |
| CAS number | 125-64-4 |
| ATC code | N05CE02 |
| PubChem | 4162 |
| DrugBank | APRD00734 |
| Chemical data | |
| Formula | C10H17NO2 |
| Mol. weight | 183.248 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 60% |
| Metabolism | ? |
| Half life | 6-16 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Methyprylon is a sedative of the piperidinedione derivative family.
[edit] External links
- Contos D, Dixon K, Guthrie R, Gerber N, Mays D (1991). "Nonlinear elimination of methyprylon (noludar) in an overdosed patient: correlation of clinical effects with plasma concentration.". J Pharm Sci 80 (8): 768-71. PMID 1686463.
- Gwilt P, Pankaskie M, Thornburg J, Zustiak R, Shoenthal D (1985). "Pharmacokinetics of methyprylon following a single oral dose.". J Pharm Sci 74 (9): 1001-3. PMID 2866242.
- Lomen P, Linet O (1976). "Hypnotic efficacy of triazolam and methyprylon ininsomniac in-patients.". J Int Med Res 4 (1): 55-8. PMID 16792.
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
